Private Equity Consulting and Venture Capital Support
Our Injection Molding Group continues to grow our business playing a critical role in helping venture capital firms and private equity groups accurately assess the value of injection molding businesses by bringing deep, hands-on technical insight to business acquisition. Injection molding business are often acquisition targets for a number of reasons and we can address them all. We evaluate the full manufacturing ecosystem—equipment condition, process capability, automation level, material handling, quality systems, as well as softer topics like business focus and culture — to determine whether reported performance is sustainable and scalable or the anticipated business roll-up is reasonable. By translating shop-floor realities into investment-relevant metrics, we help investors distinguish between businesses with durable operational advantages, those whose margins depend on fragile or poorly controlled processes or when the business concepts considered contain some critical and costly error.
Beyond diligence, which often focuses on a census of capital equipment as well as a basic functionality assessment, our Injection Molding Group helps investors model post-acquisition value creation with a practical, execution-oriented road map. We identify opportunities for operational improvement, capacity expansion, and cost reduction that are grounded in real-world manufacturing constraints rather than theoretical benchmarks. Whether supporting platform acquisitions, add-on strategies, or carve-outs, we provide clear guidance on where to invest, where to standardize, and where to avoid over capitalization. As a result, private equity and venture capital firms gain confidence that their valuation assumptions are technically sound and that their growth thesis can be realized on the factory floor.
A key strength of our work is the integrated assessment of both part molding operations and mold-making capabilities, recognizing that value is often created (or destroyed) at the intersection of the two. For part molding, we analyze cycle times, scrap rates, tooling changeover efficiency, resin sourcing strategies, and process windows to identify hidden constraints and upside opportunities. On the mold-making side, we review tool design practices, build quality, maintenance regimes, and in-house versus outsourced capacity, with particular attention to how tooling decisions affect part quality, throughput, and life cycle costs. This holistic view allows investors to understand not just current earnings, but the true capital requirements and risks embedded in the tooling base.
Beyond diligence, which often focuses on a census of capital equipment as well as a basic functionality assessment, our Injection Molding Group helps investors model post-acquisition value creation with a practical, execution-oriented road map. We identify opportunities for operational improvement, capacity expansion, and cost reduction that are grounded in real-world manufacturing constraints rather than theoretical benchmarks. Whether supporting platform acquisitions, add-on strategies, or carve-outs, we provide clear guidance on where to invest, where to standardize, and where to avoid over capitalization. As a result, private equity and venture capital firms gain confidence that their valuation assumptions are technically sound and that their growth thesis can be realized on the factory floor.
A key strength of our work is the integrated assessment of both part molding operations and mold-making capabilities, recognizing that value is often created (or destroyed) at the intersection of the two. For part molding, we analyze cycle times, scrap rates, tooling changeover efficiency, resin sourcing strategies, and process windows to identify hidden constraints and upside opportunities. On the mold-making side, we review tool design practices, build quality, maintenance regimes, and in-house versus outsourced capacity, with particular attention to how tooling decisions affect part quality, throughput, and life cycle costs. This holistic view allows investors to understand not just current earnings, but the true capital requirements and risks embedded in the tooling base.
